https://academic.oup.com/lifemeta/advance-article/doi/10.1093/lifemeta/loac025/6711379. Accessed December 27, 2022.; https://academic.oup.com/lifemeta/article/1/2/122/6711379

1947

Boccardi V, Mecocci P. Telomerase activation and human health-span: an open issue. Aging Clin Exp Res. 2018;30(2):221–3. https://pubmed.ncbi.nlm.nih.gov/28470632/

1948

Shay JW, Wright WE. Telomeres and telomerase: three decades of progress. Nat Rev Genet. 2019;20(5):299–309. https://pubmed.ncbi.nlm.nih.gov/30760854/

1949

Herrmann W, Herrmann M. The importance of telomere shortening for atherosclerosis and mortality. J Cardiovasc Dev Dis. 2020;7(3):29. https://pubmed.ncbi.nlm.nih.gov/32781553/

1950

Serrano M, Blasco MA. Cancer and ageing: convergent and divergent mechanisms. Nat Rev Mol Cell Biol. 2007;8(9):715–22. https://pubmed.ncbi.nlm.nih.gov/17717516/

1951

Bonafè M, Sabbatinelli J, Olivieri F. Exploiting the telomere machinery to put the brakes on inflamm-aging. Ageing Res Rev. 2020;59:101027. https://pubmed.ncbi.nlm.nih.gov/32068123/

1952

Stone RC, Horvath K, Kark JD, Susser E, Tishkoff SA, Aviv A. Telomere length and the cancer – atherosclerosis trade-off. PLoS Genet. 2016;12(7):e1006144. https://pubmed.ncbi.nlm.nih.gov/27386863/

1953

Shay JW, Wright WE. Telomeres and telomerase: three decades of progress. Nat Rev Genet. 2019;20(5):299–309. https://pubmed.ncbi.nlm.nih.gov/30760854/

1954

Saretzki G. Telomeres, telomerase and ageing. Subcell Biochem. 2018;90:221–308. https://pubmed.ncbi.nlm.nih.gov/30779012/

1955

Rizvi S, Raza ST, Mahdi F. Telomere length variations in aging and age-related diseases. Curr Aging Sci. 2014;7(3):161–7. https://pubmed.ncbi.nlm.nih.gov/25612739/

1956

Wang J, Liu Y, Xia Q, et al. Potential roles of telomeres and telomerase in neurodegenerative diseases. Int J Biol Macromol. 2020;163:1060–78. https://pubmed.ncbi.nlm.nih.gov/32673712/

1957

Leung CW, Laraia BA, Needham BL, et al. Soda and cell aging: associations between sugar-sweetened beverage consumption and leukocyte telomere length in healthy adults from the National Health and Nutrition Examination Surveys. Am J Public Health. 2014;104(12):2425–31. https://pubmed.ncbi.nlm.nih.gov/25322305/

1958

Huang Z, Liu C, Ruan Y, et al. Dynamics of leukocyte telomere length in adults aged 50 and older: a longitudinal population-based cohort study. GeroScience. 2021;43(2):645–54. https://pubmed.ncbi.nlm.nih.gov/33469834/

1959

Prieto-Oliveira P. Telomerase activation in the treatment of aging or degenerative diseases: a systematic review. Mol Cell Biochem. 2021;476(2):599–607. https://pubmed.ncbi.nlm.nih.gov/33001374/

1960

Zhou J, Wang J, Shen Y, et al. The association between telomere length and frailty: a systematic review and meta-analysis. Exp Gerontol. 2018;106:16–20. https://pubmed.ncbi.nlm.nih.gov/29518479/

1961

Cohen S, Janicki-Deverts D, Turner RB, et al. Association between telomere length and experimentally induced upper respiratory viral infection in healthy adults. JAMA. 2013;309(7):699–705. https://pubmed.ncbi.nlm.nih.gov/23423415/

1962

Zhan Y, Clements MS, Roberts RO, et al. Association of telomere length with general cognitive trajectories: a meta-analysis of four prospective cohort studies. Neurobiol Aging. 2018;69:111–6. https://pubmed.ncbi.nlm.nih.gov/29870951/

1963

Smith L, Luchini C, Demurtas J, et al. Telomere length and health outcomes: an umbrella review of systematic reviews and meta-analyses of observational studies. Ageing Res Rev. 2019;51:1–10. https://pubmed.ncbi.nlm.nih.gov/30776454/

1964

Herrmann W, Herrmann M. The importance of telomere shortening for atherosclerosis and mortality. J Cardiovasc Dev Dis. 2020;7(3):29. https://pubmed.ncbi.nlm.nih.gov/32781553/

1965

Zhan Y, Liu XR, Reynolds CA, Pedersen NL, Hägg S, Clements MS. Leukocyte telomere length and all-cause mortality: a between-within twin study with time-dependent effects using generalized survival models. Am J Epidemiol. 2018;187(10):2186–91. https://pubmed.ncbi.nlm.nih.gov/29961868/

1966

Christensen K, Thinggaard M, McGue M, et al. Perceived age as clinically useful biomarker of ageing: cohort study. BMJ. 2009;339:b5262. https://pubmed.ncbi.nlm.nih.gov/20008378/

1967

Christensen K, Thinggaard M, McGue M, et al. Perceived age as clinically useful biomarker of ageing: cohort study. BMJ. 2009;339:b5262. https://pubmed.ncbi.nlm.nih.gov/20008378/

1968

Zhan Y, Hägg S. Association between genetically predicted telomere length and facial skin aging in the UK Biobank: a Mendelian randomization study. GeroScience. 2021;43(3):1519–25. https://pubmed.ncbi.nlm.nih.gov/33033864/

1969

Astuti Y, Wardhana A, Watkins J, Wulaningsih W. Cigarette smoking and telomere length: a systematic review of 84 studies and meta-analysis. Environ Res. 2017;158:480–9. https://pubmed.ncbi.nlm.nih.gov/28704792/

1970

Aviv A, Shay JW. Reflections on telomere dynamics and ageing-related diseases in humans. Philos Trans R Soc Lond B Biol Sci. 2018;373(1741):20160436. https://pubmed.ncbi.nlm.nih.gov/29335375/

1971

Whittemore K, Vera E, Martínez-Nevado E, Sanpera C, Blasco MA. Telomere shortening rate predicts species life span. Proc Natl Acad Sci U S A. 2019;116(30):15122–7. https://pubmed.ncbi.nlm.nih.gov/31285335/

1972

Fick LJ, Fick GH, Li Z, et al. Telomere length correlates with life span of dog breeds. Cell Rep. 2012;2(6):1530–6. https://pubmed.ncbi.nlm.nih.gov/23260664/

1973

Muñoz-Lorente MA, Cano-Martin AC, Blasco MA. Mice with hyper-long telomeres show less metabolic aging and longer lifespans. Nat Commun. 2019;10(1):4723. https://pubmed.ncbi.nlm.nih.gov/31624261/

1974

Blackburn EH, Epel ES, Lin J. Human telomere biology: a contributory and interactive factor in aging, disease risks, and protection. Science. 2015;350(6265):1193–8. https://pubmed.ncbi.nlm.nih.gov/26785477/

1975

Zhu Y, Liu X, Ding X, Wang F, Geng X. Telomere and its role in the aging pathways: telomere shortening, cell senescence and mitochondria dysfunction. Biogerontology. 2019;20(1):1–16. https://pubmed.ncbi.nlm.nih.gov/30229407/

1976

Blackburn EH, Epel ES, Lin J. Human telomere biology: a contributory and interactive factor in aging, disease risks, and protection. Science. 2015;350(6265):1193–8. https://pubmed.ncbi.nlm.nih.gov/26785477/

1977

Tsuji A, Ishiko A, Takasaki T, Ikeda N. Estimating age of humans based on telomere shortening. Forensic Sci Int. 2002;126(3):197–9. https://pubmed.ncbi.nlm.nih.gov/12062940/

1978

Huang Z, Liu C, Ruan Y, et al. Dynamics of leukocyte telomere length in adults aged 50 and older: a longitudinal population-based cohort study. GeroScience. 2021;43(2):645–54. https://pubmed.ncbi.nlm.nih.gov/33469834/

1979

Blackburn EH. Telomeres and telomerase: the means to the end (Nobel lecture). Angew Chemie Int Ed Engl. 2010;49(41):7405–21. https://pubmed.ncbi.nlm.nih.gov/20821774/

1980

Laberthonnière C, Magdinier F, Robin JD. Bring it to an end: does telomeres size matter?